A Discrete Choice Experiment analysis to understand Treatment Preferences of Patients with Relapsed or Refractory Multiple Myeloma (RRMM) in the United States

被引：0
|
作者：
Faiman, Beth [1 ]
Le, Hoa [2 ]
Laurent, Julie [3 ]
Patel, Saurabh [2 ]
Paner-Straseviciute, Agne [2 ]
Zhang, Xinke [4 ]
Mikhael, Joseph [5 ]
机构：
[1] Cleveland Clin, Cleveland, OH USA
[2] Johnson & Johnson Innovat Med, Raritan, NJ USA
[3] Caren Part EvidentIQ, Munich, Germany
[4] Janssen Sci Affairs, Baltimore, MD USA
[5] City Hope Natl Med Ctr, Duarte, CA USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-400
引用
收藏
页码：S265 / S265
页数：1
相关论文
共 50 条
  • [21] A discrete-choice experiment to elicit the treatment preferences of patients with hidradenitis suppurativa in the United States
    Willems, D.
    Sayed, C. J.
    van der Zee, H. H.
    Ingram, J. R.
    Hinzpeter, E. -l.
    Beaudart, C.
    Evers, S. M. A. A.
    Hiligsmann, M.
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 503 - 508
  • [22] Patient-Reported Factors in Treatment Satisfaction in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
    Chari, Ajai
    Romanus, Dorothy
    DasMahapatra, Pronabesh
    Hoole, Michael
    Lowe, Maria
    Curran, Chris
    Campbell, Scott
    Bell, Jill A.
    ONCOLOGIST, 2019, 24 (11): : 1479 - 1487
  • [23] Selinexor in Combination with Pomalidomide and Dexamethasone (SPd) for Treatment of Patients with Relapsed Refractory Multiple Myeloma (RRMM)
    Chen, Christine I.
    Bahlis, Nizar J.
    Gasparetto, Cristina
    Tuchman, Sascha A.
    Lipe, Brea
    Baljevic, Muhamed
    Kotb, Rami
    Sutherland, Heather J.
    Bensinger, William I.
    Sebag, Michael
    LeBlanc, Richard
    Venner, Christopher P.
    Schiller, Gary J.
    Lentzsch, Suzanne
    Callander, Natalie S.
    Rossi, Adriana C.
    Sheehan, Heidi
    Van Domelen, Dane
    Kazuharu, Kai
    Wang, Hongwei
    Shah, Jatin
    Shacham, Sharon
    Kauffman, Michael G.
    White, Darrell J.
    BLOOD, 2020, 136
  • [24] Treatment Preferences in people with severe haemophilia A: A discrete choice experiment in the United States
    Miesbah, W.
    Valentino, L.
    O'Mahony, B.
    Forsyth, K.
    Bullinger, M.
    Sepulveda, J. M. Gonzalez
    Dashiell-Aje, E.
    Santos, S.
    Lewis, H.
    Latibeaudiere-Gardner, D.
    Tervonen, T.
    Karimi, M.
    HAEMOPHILIA, 2024, 30 : 187 - 188
  • [25] Preferences and Priorities for Relapsed Multiple Myeloma Treatments Among Patients and in the United States
    Auclair, Daniel
    Mansfield, Carol
    Fiala, Mark A.
    Chari, Ajai
    Cole, Craig E.
    Kaufman, Jonathan L.
    Orloff, Gregory J.
    Siegel, David S.
    Zonder, Jeffrey A.
    Mange, Brennan
    Yesil, Jennifer
    Dalal, Mehul
    Mikhael, Joseph R.
    PATIENT PREFERENCE AND ADHERENCE, 2022, 16 : 573 - 585
  • [26] Estimating the Effect of Individual Agents in the Treatment of Relapsed, Refractory Multiple Myeloma (RRMM)
    Hawkins, Neil
    Ramasamy, Karthik
    Dhanasiri, Sujith
    BLOOD, 2018, 132
  • [27] Real World Evaluation of Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma (RRMM)
    Maringanti, Sireesha Asoori
    Lin, Yi
    Estritis, Stathis
    Martinez-Lopez, Joaquin
    Bansal, Radhika
    Fotiou, Despina
    Corona, Magdalena
    Chhabra, Saurabh
    Brunaldi, Larissa
    Corraes, Andre De Menezes Silva
    Parrondo, Ricardo
    Kapoor, Prashant
    Ailawadhi, Sikander
    Mas, Reyes
    Tamayo, Andrea
    Dimopoulos, Meletios
    Durie, Brian
    Martin, Thomas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S506 - S507
  • [28] SLR OF ECONOMIC EVALUATION FOR TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) IN UK
    Mehta, J.
    Harrison, O.
    Barwood, C.
    Ubi, S.
    Bertranou, E.
    Bouhlabel, F.
    Low, E.
    Shah, A.
    Korde, R.
    Shah, J.
    Gaugris, S.
    VALUE IN HEALTH, 2020, 23 : S51 - S52
  • [29] Mezagitamab Induces Immunomodulatory Effect in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
    Abadier, Michael
    Estevam, Jose
    Berg, Deborah
    Fedyk, Eric Robert
    BLOOD, 2020, 136
  • [30] POMALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) PREVIOUSLY TREATED WITH LENALIDOMIDE
    Gomez, Hernando Marta
    Gironella, Merce
    Abella, Eugenia
    Cabezudo, Elena
    Motllo, Cristina
    Garcia, Antoni
    Sarra, Josep
    Mostacedo, Silvia
    Granell, Miquel
    Rosinol, Laura
    HAEMATOLOGICA, 2020, 105 : 13 - 14
12345